Zobrazeno 1 - 10 of 194 pro vyhledávání: '"Douguet L"'
1
Akademický článek
T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.
Autor: Fert I; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, 28 Rue du Dr. Roux, F-75015, Paris, France., Douguet L; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, 28 Rue du Dr. Roux, F-75015, Paris, France., Vesin B; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, 28 Rue du Dr. Roux, F-75015, Paris, France., Moncoq F; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, 28 Rue du Dr. Roux, F-75015, Paris, France., Noirat A; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, 28 Rue du Dr. Roux, F-75015, Paris, France., Authié P; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, 28 Rue du Dr. Roux, F-75015, Paris, France., Ciret S; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, 28 Rue du Dr. Roux, F-75015, Paris, France., Le Chevalier F; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, 28 Rue du Dr. Roux, F-75015, Paris, France., Blanc C; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, 28 Rue du Dr. Roux, F-75015, Paris, France., Vitrenko Y; Institut Pasteur, Université Paris Cité, Biomics Technology Platform, F-75015, Paris, France., Charneau P; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, 28 Rue du Dr. Roux, F-75015, Paris, France., Majlessi L; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, 28 Rue du Dr. Roux, F-75015, Paris, France. laleh.majlessi@pasteur.fr., Anna F; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, 28 Rue du Dr. Roux, F-75015, Paris, France. francois.anna@pasteur.fr.
Publikováno v: NPJ vaccines [NPJ Vaccines] 2024 Jun 10; Vol. 9 (1), pp. 102. Date of Electronic Publication: 2024 Jun 10.
Zobrazit plný text záznamu
2
Akademický článek
Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers.
Autor: Demidova A; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, Paris, France., Douguet L; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, Paris, France., Fert I; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, Paris, France., Wei Y; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, Paris, France., Charneau P; Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Virology Department, Paris, France., Majlessi L
Publikováno v: Expert review of vaccines [Expert Rev Vaccines] 2024 Jan-Dec; Vol. 23 (1), pp. 674-687. Date of Electronic Publication: 2024 Jul 08.
Zobrazit plný text záznamu
3
Akademický článek
Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.
Autor: Douguet L; Virology Department, Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Paris, France., Fert I; Virology Department, Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Paris, France., Lopez J; Virology Department, Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Paris, France., Vesin B; Virology Department, Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Paris, France., Le Chevalier F; Virology Department, Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Paris, France., Moncoq F; Virology Department, Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Paris, France., Authié P; Virology Department, Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Paris, France., Nguyen TM; Virology Department, Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Paris, France., Noirat A; Virology Department, Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Paris, France., Névo F; Virology Department, Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Paris, France., Blanc C; Virology Department, Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Paris, France., Bourgine M; Virology Department, Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Paris, France., Hardy D; Histopathology Platform, Institut Pasteur, Université de Paris, Paris, France., Anna F; Virology Department, Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Paris, France., Majlessi L; Virology Department, Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Paris, France., Charneau P; Virology Department, Pasteur-TheraVectys Joint Lab, Institut Pasteur, Université de Paris, Paris, France.
Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2023 Oct 11; Vol. 15 (10), pp. e17723. Date of Electronic Publication: 2023 Sep 07.
Zobrazit plný text záznamu
4
Akademický článek
A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy.
Autor: Douguet L; Université Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France. ldouguet@gmail.com., Janho Dit Hreich S; Université Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France.; FHU OncoAge, Nice, France.; Centre Antoine Lacassagne, Nice, France., Benzaquen J; Université Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France.; FHU OncoAge, Nice, France.; Centre Antoine Lacassagne, Nice, France., Seguin L; Université Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France.; FHU OncoAge, Nice, France., Juhel T; Université Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France., Dezitter X; Inserm, CHU Lille, U1286-Infinite-Institute for Translational Research in Inflammation, University of Lille, Lille, France.; Institut de Chimie Pharmaceutique Albert Lespagnol, IFR114, Lille, France., Duranton C; Université Côte d'Azur, CNRS, INSERM, LP2M, Nice, France., Ryffel B; INEM-UMR7355, Institute of Molecular Immunology and Neurogenetic, University and CNRS, Orleans, France., Kanellopoulos J; Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Saclay, Gif-sur-Yvette Cedex, France., Delarasse C; INSERM, CNRS, Institut de la Vision, Sorbonne Université, Paris, France., Renault N; Inserm, CHU Lille, U1286-Infinite-Institute for Translational Research in Inflammation, University of Lille, Lille, France.; Institut de Chimie Pharmaceutique Albert Lespagnol, IFR114, Lille, France., Furman C; Inserm, CHU Lille, U1286-Infinite-Institute for Translational Research in Inflammation, University of Lille, Lille, France.; Institut de Chimie Pharmaceutique Albert Lespagnol, IFR114, Lille, France., Homerin G; Inserm, CHU Lille, U1286-Infinite-Institute for Translational Research in Inflammation, University of Lille, Lille, France.; Hautes Etudes d'Ingénieur (HEI), JUNIA, UC Lille, Laboratoire de Chimie Durable et Santé, Lille, France., Féral C; Université Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France.; FHU OncoAge, Nice, France., Cherfils-Vicini J; Université Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France., Millet R; Inserm, CHU Lille, U1286-Infinite-Institute for Translational Research in Inflammation, University of Lille, Lille, France.; Institut de Chimie Pharmaceutique Albert Lespagnol, IFR114, Lille, France., Adriouch S; Institute for Research and Innovation in Biomedicine, Normandie University, Rouen, France., Ghinet A; Inserm, CHU Lille, U1286-Infinite-Institute for Translational Research in Inflammation, University of Lille, Lille, France.; Hautes Etudes d'Ingénieur (HEI), JUNIA, UC Lille, Laboratoire de Chimie Durable et Santé, Lille, France.; Faculty of Chemistry, 'Al. I. Cuza' University of Iasi, Iasi, Romania., Hofman P; Université Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France.; FHU OncoAge, Nice, France.; Hospital-Related Biobank (BB-0033-00025), Pasteur Hospital, Nice, France.; Laboratory of Clinical and Experimental Pathology and Biobank, Pasteur Hospital, Nice, France., Vouret-Craviari V; Université Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France. valerie.vouret@univ-cotedazur.fr.; FHU OncoAge, Nice, France. valerie.vouret@univ-cotedazur.fr.; Centre Antoine Lacassagne, Nice, France. valerie.vouret@univ-cotedazur.fr.
Publikováno v: Nature communications [Nat Commun] 2021 Jan 28; Vol. 12 (1), pp. 653. Date of Electronic Publication: 2021 Jan 28.
Zobrazit plný text záznamu
5
Akademický článek
Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?
Autor: Benzaquen J; University of Cote d'Azur, CNRS, INSERM, IRCAN, Nice, France; FHU OncoAge, Nice, France., Heeke S; University of Cote d'Azur, CNRS, INSERM, IRCAN, Nice, France; Laboratory of Clinical and Experimental Pathology and Biobank, Pasteur Hospital, Nice, France; FHU OncoAge, Nice, France., Janho Dit Hreich S; University of Cote d'Azur, CNRS, INSERM, IRCAN, Nice, France., Douguet L; University of Cote d'Azur, CNRS, INSERM, IRCAN, Nice, France., Marquette CH; University of Cote d'Azur, CNRS, INSERM, IRCAN, Nice, France; FHU OncoAge, Nice, France; University of Cote d'Azur, CHU de Nice, Department of Pulmonary Medicine, FHU OncoAge, Nice, France., Hofman P; University of Cote d'Azur, CNRS, INSERM, IRCAN, Nice, France; Laboratory of Clinical and Experimental Pathology and Biobank, Pasteur Hospital, Nice, France; Hospital-Related Biobank (BB-0033-00025), Pasteur Hospital, Nice, France; FHU OncoAge, Nice, France., Vouret-Craviari V; University of Cote d'Azur, CNRS, INSERM, IRCAN, Nice, France; FHU OncoAge, Nice, France. Electronic address: vouret@univ-cotedazur.fr.
Publikováno v: Biomedical journal [Biomed J] 2019 Jun; Vol. 42 (3), pp. 141-154. Date of Electronic Publication: 2019 Jul 15.
Zobrazit plný text záznamu
6
Akademický článek
VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness.
Autor: Ndiaye PD; University of Nice Sophia Antipolis, Institute for research on cancer and aging of Nice, CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, France., Dufies M; Centre Scientifique de Monaco, Biomedical Department, 8 Quai Antoine Ier, MC-98000 Monaco, Principality of Monaco., Giuliano S; Centre Scientifique de Monaco, Biomedical Department, 8 Quai Antoine Ier, MC-98000 Monaco, Principality of Monaco., Douguet L; University of Nice Sophia Antipolis, Institute for research on cancer and aging of Nice, CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, France., Grépin R; Centre Scientifique de Monaco, Biomedical Department, 8 Quai Antoine Ier, MC-98000 Monaco, Principality of Monaco., Durivault J; Centre Scientifique de Monaco, Biomedical Department, 8 Quai Antoine Ier, MC-98000 Monaco, Principality of Monaco., Lenormand P; University of Nice Sophia Antipolis, Institute for research on cancer and aging of Nice, CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, France., Glisse N; University of Nice Sophia Antipolis, Institute for research on cancer and aging of Nice, CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, France., Mintcheva J; University of Nice Sophia Antipolis, Institute for research on cancer and aging of Nice, CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, France., Vouret-Craviari V; University of Nice Sophia Antipolis, Institute for research on cancer and aging of Nice, CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, France., Mograbi B; University of Nice Sophia Antipolis, Institute for research on cancer and aging of Nice, CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, France., Wurmser M; Université Paris Descartes, Sorbonne Paris Cité, INSERM U1016, Institut Cochin, Paris, 75014 France; CNRS UMR 8104, Paris, 75014 France, Paris, 75014 France., Ambrosetti D; Nice University Hospital, Central laboratory of Pathology., Rioux-Leclercq N; Rennes University, Rennes University Hospital, Department of Pathology, Rennes, France., Maire P; Université Paris Descartes, Sorbonne Paris Cité, INSERM U1016, Institut Cochin, Paris, 75014 France; CNRS UMR 8104, Paris, 75014 France, Paris, 75014 France., Pagès G; University of Nice Sophia Antipolis, Institute for research on cancer and aging of Nice, CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, France.; Centre Scientifique de Monaco, Biomedical Department, 8 Quai Antoine Ier, MC-98000 Monaco, Principality of Monaco.
Publikováno v: Theranostics [Theranostics] 2019 Jan 21; Vol. 9 (3), pp. 661-675. Date of Electronic Publication: 2019 Jan 21 (Print Publication: 2019).
Zobrazit plný text záznamu
7
Akademický článek
Inflammation drives nitric oxide synthase 2 expression by γδ T cells and affects the balance between melanoma and vitiligo associated melanoma.
Autor: Douguet L; Institut National de la Santé et de la Recherche Médicale (INSERM), U1016, Institut Cochin, Paris, France.; Centre National de la Recherche Scientifique (CNRS), UMR8104, Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, Paris, France., Bod L; Institut National de la Santé et de la Recherche Médicale (INSERM), U1016, Institut Cochin, Paris, France.; Centre National de la Recherche Scientifique (CNRS), UMR8104, Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, Paris, France., Labarthe L; Institut National de la Santé et de la Recherche Médicale (INSERM), U1016, Institut Cochin, Paris, France.; Centre National de la Recherche Scientifique (CNRS), UMR8104, Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, Paris, France., Lengagne R; Institut National de la Santé et de la Recherche Médicale (INSERM), U1016, Institut Cochin, Paris, France.; Centre National de la Recherche Scientifique (CNRS), UMR8104, Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, Paris, France., Kato M; Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan., Couillin I; INEM, CNRS, UMR7355, University of Orleans, Orleans, France., Prévost-Blondel A; Institut National de la Santé et de la Recherche Médicale (INSERM), U1016, Institut Cochin, Paris, France.; Centre National de la Recherche Scientifique (CNRS), UMR8104, Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Publikováno v: Oncoimmunology [Oncoimmunology] 2018 Jul 30; Vol. 7 (9), pp. e1484979. Date of Electronic Publication: 2018 Jul 30 (Print Publication: 2018).
Zobrazit plný text záznamu
8
Akademický článek
IL-4-Induced Gene 1: A Negative Immune Checkpoint Controlling B Cell Differentiation and Activation.
Autor: Bod L; INSERM, U1016, Institut Cochin, 75014 Paris, France.; CNRS, UMR8104, 75014 Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France., Douguet L; INSERM, U1016, Institut Cochin, 75014 Paris, France.; CNRS, UMR8104, 75014 Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France., Auffray C; INSERM, U1016, Institut Cochin, 75014 Paris, France.; CNRS, UMR8104, 75014 Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France., Lengagne R; INSERM, U1016, Institut Cochin, 75014 Paris, France.; CNRS, UMR8104, 75014 Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France., Bekkat F; INSERM, U1016, Institut Cochin, 75014 Paris, France.; CNRS, UMR8104, 75014 Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France., Rondeau E; INSERM, U1016, Institut Cochin, 75014 Paris, France.; CNRS, UMR8104, 75014 Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France., Molinier-Frenkel V; INSERM, U955, Equipe 09, 94000 Créteil, France.; Faculté de Médecine, Université Paris Est, 94000 Créteil, France.; Assistance Publique - Hôpitaux de Paris, Hôpital Henri Mondor - Albert Chenevier, Service d'Immunologie Biologique, 94000 Créteil, France; and., Castellano F; INSERM, U955, Equipe 09, 94000 Créteil, France.; Faculté de Médecine, Université Paris Est, 94000 Créteil, France.; Assistance Publique - Hôpitaux de Paris, Hôpital Henri Mondor - Albert Chenevier, Plateforme de Ressources Biologiques, 94000 Créteil, France., Richard Y; INSERM, U1016, Institut Cochin, 75014 Paris, France; armelle.blondel@inserm.fr yolande.richard@inserm.fr.; CNRS, UMR8104, 75014 Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France., Prévost-Blondel A; INSERM, U1016, Institut Cochin, 75014 Paris, France; armelle.blondel@inserm.fr yolande.richard@inserm.fr.; CNRS, UMR8104, 75014 Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France.
Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2018 Feb 01; Vol. 200 (3), pp. 1027-1038. Date of Electronic Publication: 2017 Dec 29.
Zobrazit plný text záznamu
9
Akademický článek
Pan-Cancer Analysis of ART1 and its Potential Value in Gastric Cancer.
Autor: Zhiping Wu1 304095584@qq.com, Siyuan Song2, Jiayu Zhou3, Qiling Zhang2, Jiangyi Yu2
Publikováno v: Journal of Cancer. 2024, Vol. 15 Issue 12, p3684-3707. 24p.
Zobrazit plný text záznamu
10
Akademický článek
Plasmatic Inactive IL-18 Predicts a Worse Overall Survival for Advanced Non-Small-Cell Lung Cancer with Early Metabolic Progression after Immunotherapy Initiation.
Autor: Janho dit Hreich, Serena1,2 (AUTHOR) serenahreich@gmail.com, Humbert, Olivier3,4 (AUTHOR) olivier.humbert@nice.unicancer.fr, Pacé-Loscos, Tanguy5 (AUTHOR) tanguy.pace-loscos@nice.unicancer.fr, Schiappa, Renaud5 (AUTHOR) renaud.schiappa@nice.unicancer.fr, Juhel, Thierry1 (AUTHOR) thierry.juhel@univ-cotedazur.fr, Ilié, Marius1,2,6,7 (AUTHOR) ilie.m@chu-nice.fr, Ferrari, Victoria8 (AUTHOR), Benzaquen, Jonathan1,2,6 (AUTHOR) hofman.p@chu-nice.fr, Hofman, Paul1,2,6,7 (AUTHOR), Vouret-Craviari, Valérie1,2,6 (AUTHOR) valerie.vouret@univ-cotedazur.fr
Publikováno v: Cancers. Jun2024, Vol. 16 Issue 12, p2226. 16p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje